The adhesins of extraintestinal pathogenic
Escherichia coli
are essential for mediating direct interactions between the microbes and the host cell surfaces that they infect. Using fluorescence microscopy and gentamycin protection assays, we observed that 49 sepsis-associated
E. coli
(SEPEC) strains isolated from human adults adhered to and invaded Vero cells in the presence of D-mannose (100%). In addition, bacteria concentrations of approximately 2 × 10
7
CFU/mL were recovered from Vero cells following an invasion assay. Furthermore, PCR analysis of adhesin genes showed that 98.0% of these SEPEC strains tested positive for
fim
H, 69.4% for
flu
, 53.1% for
csg
A, 38.8% for
mat
, and 32.7% for
iha
. Analysis of the invasin genes showed that 16.3% of the SEPEC strains were positive for
tia
, 12.3% for
gim
B, and 10.2% for
ibe
A. Therefore, these data suggest that SEPEC adhesion to cell surfaces occurs through non-
fim
H mechanisms. Scanning electron microscopy showed the formation of microcolonies on the Vero cell surface. SEPEC invasiveness was also confirmed by the presence of intracellular bacteria, and ultrastructural analysis using electron transmission microscopy revealed bacteria inside the Vero cells. Taken together, these results demonstrate that these SEPEC strains had the ability to adhere to and invade Vero cells. Moreover, these data support the theory that renal cells may be the predominant pathway through which SEPEC enters human blood vessels.
Este trabalho visou caracterizar macro e microscopicamente o saco vitelino em pacas (Agouti paca) e cutias (Dasyprocta aguti) no início de gestação. Três embriões/fetos de pacas e três de cutias foram utilizados para a análise do saco vitelino, durante as fases iniciais de gestação. Fragmentos do saco vitelino foram removidos do embrião/feto e rotineiramente processados para inclusão em parafina (técnica histológica rotineira) e em resina Spurr (análise ultra-estrutural). Macroscopicamente, a placenta vitelínica em ambas as espécies inseria-se na superfície da placenta principal, com suas margens projetando-se completamente sobre o embrião/fetos. Na microscopia de luz, a placenta vitelínica apresentava-se constituída pelo epitélio endodérmico e um mesenquima com inúmeros vasos vitelínicos. Ultraestruturalmente, a placenta vitelínica visceral da paca era formada por células endodérmicas com núcleos na região mediana e da cutia por núcleos dispostos apicalmente; outra característica foi o grande número de mitocôndrias, vesículas de conteúdo eletrodenso e com microvilosidades. Com base nos resultados concluímos, que (1) a placenta vitelínica das duas espécies apresenta inserção na superfície da placenta principal; (2) a placenta vitelínica de paca se apóia na membrana de Reichert, diferentemente da cutia, que não possui tal membrana; (3) o cório e alantóide apresentam-se fusionados, formando a placenta corioalantoídea; e (4) o saco vitelino em ambas as espécies é invertido e vascularizado.
This study aimed to evaluate the potential of soybean-promoted acidic nitrite reduction and to correlate this activity with the content of phenolics and with the bactericidal activity against Escherichia coli O157:H7. Extracts of embrionary axes and cotyledons enriched in phenolics increased •NO formation at acidic pH at values that were 7.1 and 4.5 times higher, respectively, when compared to the reduction of the nonenriched extracts. Among the various phenolics accumulated in the soybean extracts, five stimulated nitrite reduction in the following decreasing order of potency: epicatechin gallate, chlorogenic acid, caffeic acid, galic acid and p-coumaric acid. Extracts of embrionary axes presented higher contents of epicatechin gallate and caffeic acid, compared to that of cotyledons, indicating a positive correlation between activity of the extracts and content of phenolics with regard to nitrite reducing activity. Soybean extracts enriched in phenolics interacted synergistically with acidified nitrite to prevent E. coli O157:H7 growth. The results suggest that soybean phenolics may interfere with the metabolism of •NO in an acidic environment by accelerating the reduction of nitrite, with a potential antimicrobial effect in the stomach.
Aims: To use the phage display technique to develop peptides with the capability to neutralize the cytotoxicity induced by Stx1 and Stx2 toxins produced by Shiga toxin-producing Escherichia coli (STEC). Methods and Results: The phage display technique permitted the development of three peptides, named PC7-12, P12-26 and PC7-30, which bind to the globotriaosylceramide (Gb3) receptor for Shiga toxins produced by STEC. Moreover, these peptides were capable of competing efficiently with the Shiga toxins for binding to Gb3. The peptides described herein partially inhibited the Stx-induced cytotoxicity of cell-free filtrates of STEC O157 : H7 and purified Stx toxins in Vero cells. The inhibition of lethality induced by Stx toxins in mice indicated that peptide PC7-30 inhibited the lethality caused by Stx1 (2LD 50 ) in mice. Conclusions: The phage display technique permitted the development of peptides that inhibited the cytotoxicity induced by Stx toxins in vitro. Peptide PC7-30 inhibited the lethality of Stx1 in vivo; this molecule would be a promising candidate for the development of therapeutic agents for STECrelated diseases in humans. Significance and Impact of the Study: The selection of Gb3, the common receptor for Stx1 and Stx2, may contribute to the development of efficient neutralizers for both toxins, and our approach would be an interesting alternative for the development of therapeutic molecules for the treatment of diseases caused by STEC strains.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.